​

Funding Round

Series A - Nucleus RadioPharma

Series A - Nucleus RadioPharma

Investment Firm

Overview

Nucleus RadioPharma is a new company built to ensure cancer patients can access potentially life-saving radiopharmaceuticals.

Announced Date

Oct 17, 2023

Funding Type

Series A

Highlights

Location

United States, North America

Social

Investor Lead

Eclipse Ventures

Eclipse Ventures

Eclipse Ventures is a early_stage_venture and late_stage_venture and post_ipo and seed and venture firm.

GE Healthcare

GE Healthcare

No designation

Participant Investors

8

Investor Name
Participant InvestorMayo Clinic
Participant InvestorFox Chase Cancer Center
Participant InvestorGE Healthcare
Participant InvestorEclipse Ventures
Participant InvestorEcho Global Logistics

Round Details and Background

Nucleus RadioPharma raised $56000000 on 2023-10-17 in Series A

Nucleus RadioPharma is a new company built to ensure cancer patients can access potentially life-saving radiopharmaceuticals.

Company Funding History

3

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Oct 12, 2022
Seed Round - Nucleus RadioPharma
2-6.0M
Oct 17, 2023
Series A - Nucleus RadioPharma
8-56.0M
Jun 05, 2024
Series A - Nucleus RadioPharma
1-undefined

Recent Activity

There is no recent news or activity for this profile.